COSM — Cosmos Health Inc.

Nasdaq · Consumer Discretionary · Distributors · CIK 1474167 ·
Last close
$0.21
Market Cap
$20.79M
52W High
$0.35
52W Low
$0.16
ADV30
3,813,445
Next earnings
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 17,927,892 1,381,171 -2,184,179 -2,805,423 62,369,011 514,702 42,542,652
Dec 2025 19,703,160 2,079,344 -11,243,640 -10,145,943 65,477,518 715,674 47,052,889
Sep 2025 17,110,425 2,602,618 -1,818,715 -5,352,890 69,492,758 889,441 46,357,874
Jun 2025 14,745,702 1,163,814 -2,645,319 -2,828,068 61,835,560 655,503 35,603,927

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-9,328,363
Investing CF
$-2,716,749
Financing CF
$13,842,856
CapEx
$-150,414
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.36
As of
2026-08-23

Balance + Analyst (yfinance extras)

Retained Earnings
$-135,972,696
Inventory
$5,650,458
Receivables
$21,037,783
ST Investments
$34,225
EBIT TTM
$-17,883,217
Pretax Income TTM
$-21,132,324
Interest Exp TTM
$3,249,107
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$73,727,856
EBITDA
$-16,787,216
Free Cash Flow
$-10,067,404
Enterprise Value
$36,428,088
Total Cash
$1,838,413
Total Debt
$15,976,119
Shares Out
100,633,773
Trailing EPS
$-0.67
Book Value
$0.40
ROE
-104.0%
ROA
-18.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 65,271,815 -16,540,819 -19,144,998 65,477,518 47,052,889 -8,447,614
Dec 2024 54,426,402 -15,252,850 -16,183,018 54,311,892 29,778,963 -7,717,034
Dec 2023 53,376,874 -21,831,217 -18,542,654 66,014,811 29,971,783 -15,635,999
Dec 2022 50,347,652 -7,474,036 -13,830,371 68,038,621 28,381,912 -14,870,639

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.07

Peers — same industry

TickerNameMarket CapLastDaily %
MWYN Marwynn Holdings, Inc. $21.20M $1.05
UUU UNIVERSAL SAFETY PRODUCTS, INC. $19.56M $6.46
PN PN Smart Energy Ltd $22.96M $2.67
SPRS SURGE COMPONENTS INC $24.09M $4.20
TMDE TMD Energy Ltd $17.44M $0.74

News headlines (Yahoo Finance, 1h cache)

Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
2026-08-24 19:40 · Yahoo
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expe
2026-08-20 13:30 · Yahoo
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M S
2026-08-19 13:00 · Yahoo
COSM Produces Stellar Quarter
2026-08-19 11:44 · Yahoo
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
2026-07-27 17:05 · Yahoo
COSM Marking Huge Growth and Buying Back Shares
2026-07-24 11:06 · Yahoo
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
2026-07-20 19:46 · Yahoo
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
2026-07-17 18:55 · Yahoo
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
2026-07-15 18:15 · Yahoo
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
2026-07-14 18:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.